Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
12/05/2016 12/06/2016 12/07/2016 12/08/2016 12/09/2016 Date
88.15(c) 88.16(c) 90.1(c) 93.17(c) 94.54(c) Last
2 458 814 2 139 658 3 549 654 5 497 071 3 269 236 Volume
+1.15% +0.01% +2.20% +3.41% +1.47% Change
More quotes
Financials (€)
Sales 2016 46 701 M
EBIT 2016 8 730 M
Net income 2016 4 740 M
Debt 2016 16 402 M
Yield 2016 2,83%
Sales 2017 48 664 M
EBIT 2017 9 783 M
Net income 2017 5 406 M
Debt 2017 12 882 M
Yield 2017 3,04%
P/E ratio 2016 16,53
P/E ratio 2017 14,76
EV / Sales2016 2,03x
EV / Sales2017 1,87x
Capitalization 78 180 M
More Financials
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
02/22 | 07:30amEarnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
12/09DJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BAYER : Modification/Amendment - Preventive Maintenance & service solution on ex..
12/07 COVESTRO : Pittsburgh International Airport and Condor Airlines Add New Nonstop ..
12/07 BAYER STRENGTHENS U.S. ANIMAL HEALTH : -- Boehringer Ingelheim Vetmedica, Inc. a..
12/06 MONSANTO COMPANY : - Leading Independent Proxy Advisory Firms ISS and Glass Lewi..
12/05 COVESTRO : Assigned Patent
12/02 BAYER : Sources Sought - Preventive Maintenance & service solution on existing B..
12/02 BAYER : Sources Sought Notice - J-- Preventive Maintenance & service solution on..
11/24 BAYER : supports public access to safety-relevant crop protection study reports
11/23 Global Milnacipran HCl Market 2016- Pfizer Inc (US), Bayer HealthCare Pharmac..
More news
Sector news : Pharmaceuticals - NEC
12/09 FTSE records best week since July, Sky surges 27 percent on Fox bid
12/09DJASTRAZENECA : FDA Accepts License Application for Durvalumab
12/09DJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
11/17Good timing to anticipate the return of volatility
10/07A technical turn-around configuration
More Strategies
News from SeekingAlpha
12/08 Top Picks For 2017
12/05 Monsanto Acquisition Has Driven Bayer Deep Into Value Territory
12/05 Precision AML Trial Adds Pharma Candidates To The Mix
12/05 J&J Target Offers Over 20% Upside
11/30 A Guide To Investing In Water
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 107 €
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Human Resources, Technology & Sustainability
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-18.36%82 541
JOHNSON & JOHNSON9.29%305 407
ROCHE HOLDING LTD.-17.58%193 824
PFIZER INC.-4.15%192 367
NOVARTIS AG-18.49%182 959
MERCK & CO., INC.15.92%168 820
More Results